This clinical trial is focused on studying a condition known as polycystic ovary syndrome (PCOS), which affects adolescent girls and young adult women. PCOS is a common hormonal disorder that can cause irregular menstrual cycles, excess hair growth, acne, and sometimes difficulty with fertility. The study is testing a treatment called SPIOMET, which is a combination of three medications: spironolactone, pioglitazone, and metformin. These medications are taken in tablet form and are designed to help manage the symptoms of PCOS by normalizing ovulation, which is the release of eggs from the ovaries.

The purpose of the study is to evaluate how effective and safe SPIOMET is for treating PCOS in young women. Participants in the study will be randomly assigned to receive either the SPIOMET tablets or a placebo. The study will last for a period of time during which participants will take the medication and attend regular check-ups to monitor their health and the effects of the treatment. The study aims to see if SPIOMET can help regulate menstrual cycles and improve other symptoms associated with PCOS.

Throughout the study, various health indicators will be monitored, including weight, height, and hormone levels. Participants will also be asked about their experiences with the medication, including any side effects they may encounter. The study will help determine if SPIOMET is a viable treatment option for young women with PCOS, potentially offering a new way to manage this condition.